Creative Realities Announces Addition of Tamra Koshewa as CFO

(NASDAQ:CREX),(NASDAQ:CREXW), LOUISVILLE, Ky, Nov. 25, 2025 (GLOBE NEWSWIRE) — Creative Realities, Inc. (“Creative Realities,” “CRI,” or the “Company”) (NASDAQ: CREX), a leading provider of digital signage, media and AdTech solutions, today announced that it has hired Tamra Koshewa as its new Chief Financial Officer (“CFO”) effective December 1, 2025. Ms. Koshewa is an accomplished finance […]

Eisai Completes Rolling Submission to US FDA for LEQEMBI(R) IQLIK(TM) (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer’s Disease Under Fast Track Status

(NASDAQ:BIIB), TOKYO and CAMBRIDGE, Mass., Nov. 25, 2025 (GLOBE NEWSWIRE) — Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today that Eisai has completed the rolling submission of the Supplemental Biologics License Application (sBLA) to the U.S. Food and

BridgeBio to Participate in December Investor Conferences

(NASDAQ:BBIO), PALO ALTO, Calif., Nov. 25, 2025 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced that members of its management team will participate in fireside chats at the following healthcare investor conferences: Piper Sandler Healthcare Conference, New York, NY:

Parsons to Present at Goldman Sachs Industrials and Materials Conference

(NYSE:PSN), CHANTILLY, Va., Nov. 25, 2025 (GLOBE NEWSWIRE) — Parsons Corporation (NYSE: PSN) announced today that Carey Smith, chair, president, and chief executive officer, and Matt Ofilos, chief financial officer, will participate in a fireside chat question and answer session at the Goldman Sachs Industrials and Materials Conference on Wednesday, December 3, 2025, at approximately

Dragonfly Energy Broadens Product Lineup to Drive Growth Beyond Batteries

(NASDAQ:DFLI),(NASDAQ:DFLIW), RENO, Nev., Nov. 25, 2025 (GLOBE NEWSWIRE) — Dragonfly Energy Holdings Corp. (Nasdaq: DFLI) (“Dragonfly Energy” or the “Company”), an industry leader in energy storage and maker of Battle Born Batteries(R), today announced a major expansion of its Battle Born(R) product portfolio. The Company is introducing new inverter/chargers, Base Series batteries, and a redesigned

BrainsWay to Host Virtual Analyst & Investor Day to Discuss the Company’s Growth Strategy and Deep TMS(TM) Treatment December 1, 2025

(TASE:BWAY.TA),(NasdaqGM:BWAY), BURLINGTON, Mass. and JERUSALEM, Nov. 25, 2025 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation technologies, today announced that it will host a virtual Analyst & Investor Day on Monday, December 1, 2025 at 10:00 AM ET, during which company management

Nokia Canada breaks ground on new Ottawa innovation campus, helping to shape the future of Canadian Tech leadership

(Helsinki:NOKIA),(Irish:IRSH),(LSE:0HAF),(Paris:NOKIA), Press Release Nokia Canada breaks ground on new Ottawa innovation campus, helping to shape the future of Canadian Tech leadership Major investment cements Canadian leadership in AI, quantum, and next-generation connectivity while driving sustainable growth and world-class talent development Project showcases the strength of Nokia's strategic partnerships with the Government of Canada, Government of

Eisai Completes Rolling Submission to U.S. FDA for LEQEMBI® IQLIK™ (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer’s Disease Under Fast Track Status

LEQEMBI IQLIK, if approved for initiation dosing, would be the first and only anti-amyloid treatment to offer at-home injection from the start of therapy to help patients and care partners treat this progressive, relentless disease Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher

Medicare Finalizes Reimbursement for Caristo’s CaRi-Plaque™ Across Hospital and Office Settings

New OPPS and PFS reimbursement rates give hospitals, imaging centers and physicians a unified path to use AI plaque analysis starting 2026 Caristo Diagnostics, on a mission to transform the diagnosis and treatment of cardiovascular disease, announced today that the Centers for Medicare & Medicaid Services (CMS) has set a $950.50 Medicare reimbursement rate under

Keurig Dr Pepper Appoints Anthony DiSilvestro as Chief Financial Officer

Keurig Dr Pepper (NASDAQ: KDP) today announced the appointment of Anthony DiSilvestro to the position of Chief Financial Officer, effective immediately. DiSilvestro will report to Chief Executive Officer Tim Cofer and lead the Company's Finance and Technology organizations. DiSilvestro has more than 40 years of diversified industry experience, including a proven track record of strategic

Scroll to Top